7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 
      
    		                                     
      cash flows from operating activities
    		                                     
      net income
    		-39,339,000 -34,771,000 -11,655,000 131,674,000 -33,210,000 -30,616,000 207,340,000 27,335,000 -34,105,000 -38,460,000 -33,725,000 -34,194,000 -31,232,000 -41,037,000 -20,930,000 -36,907,000 -33,804,000 -30,842,000 -23,998,000 -18,886,000 -7,763,000 -19,421,000 -20,080,000 -17,501,000 -16,409,000 -29,174,000 -14,103,000 -13,865,000 -8,735,000 -8,663,000 -7,661,000 -3,052,000 -4,825,000 -14,979,000 -14,101,000 -11,248,000 -7,084,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                                     
      stock-based compensation
    		10,559,000 10,912,000 13,802,000 9,093,000 10,165,000 8,944,000 9,352,000 6,601,000 6,765,000 8,343,000 7,584,000 5,512,000 5,950,000 6,805,000 5,935,000 5,024,000 4,775,000 3,936,000 2,660,000 1,967,000 1,888,000 1,996,000 2,048,000 2,160,000 2,201,000 2,013,000 1,979,000 2,072,000 2,017,000 1,645,000 1,185,000 1,189,000 1,207,000 1,002,000 843,000 1,520,000 448,000 
      non-cash lease expense
    		106,000 568,000 569,000                                   
      depreciation
    		361,000 304,000 239,000 118,000 231,000 241,000 236,000 248,000 244,000 237,000 248,000  270,000 259,000 249,000                       
      accretion of discount on marketable securities
    		-1,684,000 -1,914,000 -2,289,000 -2,760,000 -2,838,000 -1,662,000 -1,615,000                               
      net realized loss on sale of marketable securities
    		-1,000 0 5,000                                   
      changes in operating assets and liabilities:
    		                                     
      receivable from collaboration partner
    		-583,000 0 165,000,000 -165,000,000 43,000 300,000,000 -290,043,000 -10,000,000 39,000 12,000 -41,000                           
      prepaid expenses and other assets
    		50,000 -1,097,000 -948,000 320,000 -1,163,000 -2,010,000 -915,000 171,000 -629,000 1,424,000 787,000 3,341,000 668,000 -1,534,000 1,279,000 -595,000 -1,211,000 -1,478,000 57,000 464,000 -1,318,000 -1,054,000 806,000 -1,234,000 218,000 -1,398,000 -406,000 591,000 -281,000 -343,000 1,150,000 -1,367,000      
      accounts payable
    		2,418,000 375,000 1,237,000 -1,430,000 -355,000 -198,000 2,825,000 -597,000 -3,204,000 552,000 381,000 -1,076,000 3,305,000 -5,743,000 5,559,000 895,000 -7,159,000 5,218,000 -344,000 277,000 -41,000 -840,000 913,000 1,165,000 -1,167,000 -3,694,000 696,000 813,000 2,603,000 993,000 21,000 -1,005,000 -332,000 1,579,000 -151,000 -272,000 72,000 
      accrued expenses and other payables
    		7,545,000 3,439,000 -11,817,000 3,228,000 5,290,000 -1,359,000 -2,870,000 -5,338,000 5,402,000 2,722,000 -8,383,000 -4,588,000 -6,574,000 3,557,000 -5,110,000 4,704,000 13,007,000 2,059,000 -673,000 2,710,000 2,748,000 1,082,000 -700,000 1,879,000 -462,000 2,734,000 -3,053,000 665,000 -2,738,000 3,010,000 974,000 1,522,000 1,754,000 158,000 1,359,000 2,190,000 1,003,000 
      payable to collaboration partner
    		   0 0   0 -7,000 -12,000 -47,000                           
      income taxes payable
    		0 -1,889,000 -800,000 1,640,000 -1,601,000 -676,000 3,326,000                               
      deferred revenue
    		-3,075,000 -5,008,000 -5,496,000 -5,638,000 -4,675,000 -4,167,000 45,047,000                               
      operating lease liability
    		-581,000 -237,000 341,000 -841,000 -166,000 -523,000 -696,000 -696,000 -693,000 -680,000 -674,000 -675,000 -671,000 -661,000 -654,000 -556,000 -506,000 -496,000 -491,000 -491,000 -492,000 -481,000 -477,000 -476,000 -478,000 -468,000 -463,000           
      net cash from operating activities
    		-1,937,000 -28,780,000 125,363,000 -29,178,000 -27,863,000 268,622,000 -27,429,000 16,960,000 -26,611,000 -26,238,000 -34,347,000 -31,635,000 -25,201,000 -13,635,000 -37,666,000 -26,939,000 -28,470,000 -23,700,000 -28,756,000 -18,867,000 -16,287,000 -21,482,000 -15,848,000 -14,289,000 -14,246,000 3,670,000 -16,662,000 -10,135,000 -9,276,000 -15,398,000 -15,138,000 -14,149,000 40,704,000 -12,327,000 -10,356,000 -9,680,000 -6,980,000 
      capex
    		-183,000 -743,000 -512,000 -589,000 -725,000 202,000 -197,000 39,000 -462,000 -130,000 5,000 -112,000 -223,000 -403,000 -38,000 -77,000 -304,000 -534,000 -43,000 -67,000 -69,000 -117,000 -133,000 -275,000 384,000 -1,459,000 483,000 -62,000 -148,000 -96,000 -172,000 0 -226,000 -448,000 70,000 -52,000 -48,000 
      free cash flows
    		-2,120,000 -29,523,000 124,851,000 -29,767,000 -28,588,000 268,824,000 -27,626,000 16,999,000 -27,073,000 -26,368,000 -34,342,000 -31,747,000 -25,424,000 -14,038,000 -37,704,000 -27,016,000 -28,774,000 -24,234,000 -28,799,000 -18,934,000 -16,356,000 -21,599,000 -15,981,000 -14,564,000 -13,862,000 2,211,000 -16,179,000 -10,197,000 -9,424,000 -15,494,000 -15,310,000 -14,149,000 40,478,000 -12,775,000 -10,286,000 -9,732,000 -7,028,000 
      cash flows from investing activities
    		                                     
      purchase of marketable securities
    		-161,117,000 -67,154,000 -214,040,000 -114,409,000 -266,666,000 -174,956,000 -65,671,000 -97,968,000 -58,955,000 -6,062,000 -28,060,000 -80,595,000 -32,158,000 -46,289,000 -55,832,000 -30,687,000 -92,442,000 -76,255,000 -87,205,000 -132,427,000 -80,847,000 -45,870,000 -20,883,000               
      proceeds from maturities of marketable securities
    		102,650,000 122,777,000 113,180,000 105,994,000 58,731,000 86,865,000 71,984,000 36,700,000 45,800,000 32,000,000 37,896,000 84,600,000 89,595,000 81,313,000 51,629,000 58,750,000 48,000,000 84,528,000 80,552,000 58,150,000 26,800,000 40,832,000 63,751,000               
      proceeds from sale of marketable securities
    		0 0 7,003,000                                   
      purchases of property and equipment
    		-88,000 -813,000 -545,000 -310,000 -775,000 -28,000 -242,000 -19,000 -404,000 -176,000 -10,000 -70,000 -162,000 -290,000 -273,000 -196,000 -265,000 -500,000 -140,000 -125,000 -75,000 -133,000 -138,000 -218,000 309,000 -892,000 -166,000 -62,000 -148,000 -68,000 -208,000       
      net cash from investing activities
    		-58,555,000 54,810,000 -94,402,000 -8,725,000 -208,710,000 -88,119,000 6,071,000 -61,287,000 -13,559,000 25,762,000 9,826,000 3,935,000 57,275,000 34,734,000 -4,476,000 27,867,000 -44,707,000 7,773,000 -6,793,000 -74,402,000   42,730,000 -12,554,000 -32,039,000 -13,225,000 4,108,000   9,591,000 -21,844,000 4,752,000 -772,000 13,093,000 -1,250,000 -64,325,000 3,884,000 
      cash flows from financing activities
    		                                     
      proceeds from issuance of common stock upon exercise of stock options and purchases under employee stock purchase plan
    		5,659,000 2,925,000 11,922,000 4,031,000 12,051,000 2,572,000 7,799,000 519,000 1,021,000 973,000 2,261,000 553,000 682,000 655,000 2,558,000 2,339,000 1,381,000 1,247,000 1,316,000 313,000   406,000 14,000 1,288,000 87,000 390,000 2,000 328,000 74,000 530,000 218,000 328,000 87,000 374,000   
      tax withholding payments related to net settlement of restricted stock units
    		0 0 -479,000 0 0 0 -600,000 0 0 -669,000 -100,000 0 -2,000 0 -186,000 0 0 0 -189,000                   
      net cash from financing activities
    		5,659,000 2,925,000 11,443,000 4,031,000 12,051,000 2,572,000 7,199,000 527,000 35,315,000 108,172,000 26,463,000 553,000 680,000 680,000 16,925,000 2,173,000 1,381,000 125,390,000 979,000 126,981,000 7,669,000 112,577,000 399,000 9,779,000 25,237,000 10,630,000 390,000 479,000 23,032,000 74,000 530,000 65,062,000 31,000 87,000 374,000 -852,000 85,278,000 
      net increase in cash, cash equivalents and restricted cash
    		-54,833,000 28,955,000 42,404,000 -33,872,000 -224,522,000 183,075,000 -14,159,000 -43,800,000 -4,855,000 107,696,000 1,942,000 -27,072,000 32,579,000   3,123,000 -71,870,000 109,412,000 -34,593,000 33,733,000 -62,617,000 86,027,000 27,209,000     -5,194,000    55,634,000 40,030,000     
      cash, cash equivalents and restricted cash, beginning of period
    		0 0 97,474,000 0 0 0 186,952,000 0 0 0 125,969,000 0 0 0 123,890,000 0 0 0 117,818,000 0 0 0 33,466,000 0 0 0 82,693,000      0     
      cash, cash equivalents and restricted cash, end of period
    		-54,833,000 28,955,000 139,878,000 -33,872,000 -224,522,000 183,075,000 172,793,000 -43,800,000 -4,855,000 107,696,000 127,911,000 -27,072,000 32,579,000 21,760,000 98,702,000 3,123,000 -71,870,000 109,412,000 83,225,000 33,733,000 -62,617,000 86,027,000 60,675,000 -17,189,000 -20,948,000 1,066,000 70,537,000 -5,194,000 23,563,000    40,030,000     
      supplemental disclosure of non-cash financing and investing information:
    		                                     
      leasehold improvements obtained under tenant improvement allowance
    		   808,000 97,000                                 
      purchases of property and equipment in accounts payable and accrued liabilities
    		-95,000 70,000 33,000 -279,000 50,000 230,000 45,000 58,000 -58,000 46,000 15,000 -42,000 -61,000 -113,000 235,000 119,000 -39,000 -34,000 97,000 58,000 6,000 16,000 5,000 -57,000 75,000 -567,000 649,000           
      right-of-use asset obtained in exchange for lease obligation
    		   0 0                                 
      contract asset
    		 538,000 -22,825,000                                   
      operating lease right-of-use asset amortization
    		   418,000 416,000 651,000 584,000 584,000 583,000 584,000 584,000 584,000 583,000 584,000 584,000 584,000 491,000 443,000 444,000 444,000 444,000 443,000 444,000 445,000 444,000 444,000 459,000           
      other
    		       0 0 0 194,000                           
      research and development tax incentive receivable
    		           -33,000    -921,000 828,000 -931,000 -751,000 -473,000 -239,000 -116,000 -162,000 174,000   -441,000 -332,000 1,059,000 -357,000 -606,000 -460,000 2,009,000 -377,000 -102,000   
      proceeds from public offering of common stock, net of issuance costs
    		       8,000 -78,000       -166,000 0   107,825,000 -211,000                 
      proceeds from at-the-market offering, net of issuance costs
    		       0 0 0 24,302,000 0 0 0 14,553,000     18,843,000 6,385,000   0 23,949,000             
      proceeds from exercise of warrants in exchange for issuance of pre-funded warrants
    		       0                              
      proceeds from issuance of common stock upon exercise of warrants
    		       0                              
      issuance costs related to prior period common stock offering
    		           0 0                         
      effect of exchange rate changes on cash, cash equivalents and restricted cash
    		           75,000 -175,000 -19,000 29,000 22,000 -74,000 -51,000 -23,000 21,000 123,000 103,000 -72,000 -125,000   8,000 -87,000 -110,000   -31,000 67,000     
      supplemental disclosure of cash flow information:
    		                                     
      cash paid for taxes
    		                                     
      issuance costs related to common stock offering included in accrued liabilities and other payables
    		              25,000 -166,000 -6,000 139,000 58,000                   
      amortization of discount/premium on marketable securities
    		       -1,348,000 -1,006,000                             
      other liabilities
    		                                     
      (accretion)/amortization of discount/premium on marketable securities
    		          -1,255,000                           
      net amortization of (discount) premium on marketable securities
    		                                     
      depreciation and amortization
    		                 185,000 180,000 188,000 182,000 202,000 217,000 202,000 195,000 176,000 130,000 128,000 151,000 170,000 78,000 117,000 108,000 93,000 88,000 75,000 83,000 
      change in deferred tax asset
    		                   34,000 -8,000 1,229,000 183,000 773,000 -102,000 -1,626,000 180,000           
      loss on early repayment of debt
    		                   0 0                 
      receivable from collaboration partner – related party
    		                                     
      payable to collaboration partner – related party
    		                                     
      deferred revenue – related party
    		                                     
      early repayment of long-term debt
    		                   0 0                 
      issuance costs related to long-term debt
    		                   0 0                 
      cash paid for interest
    		                                     
      issuance costs related to at-the-market offering of common stock included in prepaid expenses and other assets at the end of the previous year
    		                   0 0                 
      issuance costs related to common stock offering included in prepaid expenses and other assets at the end of the previous year
    		                                     
      net amortization of premium on marketable securities
    		            -89,000 96,000 358,000                       
      receivable from collaboration partner - related party
    		            -82,000 25,107,000 -23,584,000 1,072,000 4,439,000 -3,081,000 -1,570,000 363,000 208,000 597,000 3,161,000 -4,810,000   -474,000 -1,000 1,198,000 -3,062,000 -906,000 -1,296,000      
      payable to collaboration partner - related party
    		            -48,000 -300,000 -519,000 -222,000 -10,275,000 4,573,000 4,091,000 656,000 1,074,000 -113,000 -146,000 242,000 210,000 -401,000 150,000 297,000 488,000 -103,000 379,000       
      deferred revenue - related party
    		            0 -768,000 -833,000 -640,000 232,000 -3,759,000 -8,709,000 -6,400,000 -13,136,000 -5,032,000 -2,485,000 2,852,000 -2,889,000 34,566,000 -1,222,000 253,000 -5,232,000 -8,678,000 -9,872,000 -9,987,000      
      issuance costs related to prior common stock offering
    		                                     
      net decrease in cash, cash equivalents and restricted cash
    		              -25,188,000          -20,948,000 1,066,000 -12,156,000   -5,713,000 -36,452,000       
      issuance costs related to common stock offering included in accrued liabilities and other payables at the end of the previous year
    		                  205,000                   
      net amortization of premium (accretion of discount) on marketable securities
    		               509,000 500,000 473,000 348,000                   
      gain on disposal of property and equipment
    		                                     
      proceeds from issuance of long-term debt, net of issuance costs
    		                                     
      amortization of debt issuance costs and accretion of debt discount
    		                   137,000 0 -23,000 45,000               
      issuance costs related to at-the-market offering of common stock included in accrued liabilities and other payables
    		                                     
      ​
    		                                     
      foreign currency remeasurement loss
    		                      549,000               
      issuance costs related to common stock offering
    		                  -148,000                   
      issuance costs related to issuance of long-term debt
    		                                     
      other liability
    		                   -49,000 78,000                 
      proceeds from issuance of common stock and warrants in private placement, net of issuance costs
    		                           -6,000          
      issuance costs related to public offering of common stock included in accrued liabilities and other payables
    		                   180,000 -208,000                 
      issuance costs related to public offering of common stock included in prepaid expenses and other assets at the end of the previous year
    		                   -1,000 0                 
      fair value of common stock retired in exchange for issuance of common stock warrant
    		                                     
      accretion of discount on marketable securities, net of premium amortization
    		                    88,000 -79,000 -164,000               
      net cash from (used) in investing activities
    		                                     
      proceeds from issuance of common stock upon under equity incentive and employee stock purchase plans
    		                                     
      tenant improvement allowance reimbursement
    		                         0 469,000           
      supplemental disclosures of non-cash financing and investing information:
    		                                     
      amortization of issuance costs and accretion of final payment fee for long-term debt
    		                                     
      net (accretion of discount) amortization of premium on marketable securities
    		                                     
      proceeds from issuance of common stock and warrants in private placement, net of issuance costs
    		                                     
      supplemental disclosures of cash flow information:
    		                                     
      deferred offering costs in accounts payable and accrued liabilities
    		                                     
      acquisition of new equipment upon trade-in for existing equipment
    		                                     
      net (accretion of discount) amortization of premium on available-for-sale securities
    		                        -188,000 -115,000 -94,000           
      purchase of available-for-sale securities
    		                        -65,348,000 -30,733,000 -21,726,000 -19,113,000 -12,935,000 -13,376,000 -25,636,000 -11,392,000 -20,152,000 0 -8,002,000 -66,773,000 0 
      proceeds from maturities of available-for-sale securities
    		                        33,000,000 18,400,000 26,000,000 23,724,000 23,000,000 23,035,000 4,000,000 16,200,000 19,570,000 13,465,000 6,800,000 2,500,000 3,900,000 
      receivable from collaboration partner and contract asset - related party
    		                                     
      net amortization of premium on available-for-sale securities
    		                           -98,000 194,000 -10,000 120,000 190,000      
      change in fair value associated with redeemable convertible preferred stock tranche liability
    		                                   0 0 
      change in fair value of redeemable convertible preferred stock warrant liability
    		                                   0 0 
      proceeds from issuance of redeemable convertible preferred stock, net of issuance costs
    		                                   -20,000 0 
      cash, cash equivalents and restricted cash, beginning of year
    		                           0 0 0 106,489,000       
      purchases of property and equipment in accounts payable
    		                             -28,000 36,000       
      conversion of redeemable convertible preferred stock to common stock at closing of initial public offering
    		                                   0  
      settlement of fair value of redeemable convertible preferred stock liability
    		                                   0 0 
      reclassification of preferred stock warrant liability to equity
    		                                   0 0 
      accretion of redeemable convertible preferred stock
    		                                   0 293,000 
      loss on disposal of property and equipment
    		                                   0 0 
      net cash from by investing activities
    		                                     
      proceeds from issuance of common stock in at-the-market offerings, net of issuance costs
    		                                     
      payment of deferred offering costs
    		                                     
      cash, cash equivalents and restricted cash, end of year
    		                              70,037,000       
      (gain) loss on disposal of property and equipment
    		                               0 3,000     
      proceeds from issuance of common stock, net of issuance costs
    		                                     
      supplemental disclosures of non-cash financing information:
    		                                     
      tranche liability in connection with the series c redeemable convertible preferred stock financing
    		                                     
      purchase of property and equipment
    		                                -190,000 -372,000 -48,000 -52,000 -48,000 
      proceeds from issuance of redeemable preferred stock, net of issuance costs
    		                                     
      proceeds from issuance of initial public offering, net of issuance cost
    		                                     
      supplemental non-cash financing and investing activities
    		                                     
      acquisition of equipment in trade-in
    		                                0     
      purchase of property and equipment in accounts payable and accrued liabilities
    		                                -36,000 -76,000 118,000   
      amortization of premium on available-for-sale securities
    		                                 150,000 122,000 35,000 10,000 
      prepaid expenses and other current assets
    		                                 112,000 1,586,000 -1,621,000 -1,313,000 
      other assets
    		                                   0 0 
      supplemental disclosures of non-cash financing and investing information
    		                                     
      effect of exchange rate changes on cash and cash equivalents
    		                                  115,000   
      net increase in cash and cash equivalents
    		                                  -11,117,000 -74,940,000 82,256,000 
      cash, beginning of period
    		                                  21,094,000   
      cash, end of period
    		                                  9,977,000   
      offering costs in accounts payable and accrued liabilities
    		                                     
      cash flows from operating actitivies
    		                                     
      research and development tax credit receivable
    		                                     
      proceeds from sale of property and equipment
    		                                   0  
      proceeds from issuance of redeemable convertible preferred stock upon exercise of preferred stock warrant liability
    		                                     
      proceeds from issuance of common stock upon exercise of stock options
    		                                   8,000 0 
      proceeds from issuance of common stock upon initial public offering, net of issuance costs
    		                                     
      effect on exchange rate changes on cash and cash equivalents
    		                                   -83,000 74,000 
      cash and cash equivalents, beginning of year
    		                                     
      cash and cash equivalents, end of year
    		                                     
      purchase of property and equipment in accounts payable
    		                                     
      cash and cash equivalents, beginning of period
    		                                    0 
      cash and cash equivalents, end of period
    		                                    82,256,000 
      supplemental disclosures of non-cash financing information
    		                                     
      payments of deferred offering costs
    		                                     
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.